Company: BNRG
Filing Date: 2025-05-14
Form Type: 424B4
Source: 0001213900-25-042979
Chunk: 46

Company: Brenmiller Energy Ltd.
Filing Date: 2025-05-14
Form: 424B4
Chunk 46
---
 of our Ordinary Shares, including any voting rights, until they
exercise their Series C Warrants.

Fundamental Transaction.
In the event of a fundamental transaction, as described in the Series C Warrants and generally including (i) we, directly or indirectly,
in one or more related transactions effect any merger or consolidation with or into another person, (ii) we (or any of our subsidiaries),
directly or indirectly, effect any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of our assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by us or another person) is completed pursuant to which holders of our Ordinary Shares are permitted to sell, tender or
exchange their shares for other securities, cash or property and has been accepted by the holders of more than 50% of our outstanding
Ordinary Shares or more than 50% of the voting power of our common equity, (iv) we, directly or indirectly, in one or more related transactions
effect any reclassification, reorganization or recapitalization of the Ordinary Shares or any compulsory share exchange pursuant to which
the Ordinary Shares are effectively converted into or exchanged for other securities, cash or property, or (v) we, directly or indirectly,
in one or more related transactions consummate a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another person or group of persons whereby
such other person or group acquires more than 50% of the outstanding Ordinary Shares or more than 50% of the voting power of our common
equity, then, upon any subsequent exercise of the Series C Warrant, the holder shall have the right to receive, for each Ordinary Share
underlying a Series C Warrant that would have been issuable upon such exercise immediately prior to the occurrence of such fundamental
transaction, at the option of the holder, the number of Ordinary Shares of the successor or acquiring corporation or of us, if we are
the surviving corporation, and any additional consideration, or the Alternate Consideration, receivable as a result of such fundamental
transaction by a holder of the number of Ordinary Shares for which the Series C Warrant is exercisable immediately prior to such fundamental
transaction.

<div align='center'>27</div>

Notwithstanding anything
to the contrary, in